IDH3B and esophageal squamous cell carcinoma: highlighted the pivotal role of IDH3 in ESCC, specifically, the overexpression of IDH3β (an important regulator of the cell cycle), could enhance glucose uptake, promote cell proliferation, and high expression of IDH3β correlated with poor OS in ESCC patients, suggesting a potential application of IDH3β in prognosis (25).